Paul A. Friedman,Jordan S. Fridman,Monica E. Luchi,William V. Williams
申请号：
US15156125
公开号：
US20170087158A1
申请日:
2016.05.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present application relates to Janus kinase (JAK) inhibitors, including 3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, for the treatment of a dry eye disorder or ameliorating a particular symptom of a dry eye disorder, such as eye discomfort, visual disturbance, tear film instability, tear hyperosmolarity, and inflammation of the ocular surface, as well as kits and compositions, including topical compositions, related thereto.
